Tenon Medical, Inc. (TNON) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Tenon Medical, Inc., a Delaware corporation, on August 6, 2026. The report details a material corporate action approved by stockholders at the 2026 Annual Meeting held on July 23, 2026. The Company is an emerging growth company listed on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a capital structure modification rather than operational financial performance.
Material Changes
- Reverse Stock Split: The Company effected a 1-for-35 reverse stock split of its Common Stock, effective as of 12:01 a.m. Eastern Time on August 10, 2026.
- Share Consolidation: Every 35 shares of issued and outstanding Common Stock were automatically combined into one share. Fractional entitlements were rounded up to the next whole number.
- Trading Adjustments: Common Stock began trading on a reverse stock split-adjusted basis on August 10, 2026, under the symbol "TNON." The new CUSIP number is 88066N402.
- Equity Instrument Adjustments: Proportionate adjustments were made to the exercise prices and share counts for outstanding stock options, warrants, and restricted stock units (RSUs).
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future financial performance, or specific risk factors beyond the standard incorporation of the Certificate of Amendment. The primary purpose of the filing is to disclose the execution of the reverse stock split to maintain compliance with Nasdaq listing standards.
Investor Verification Checklist
- Verify the new CUSIP number (88066N402) for the Common Stock.
- Confirm the adjusted number of shares held in brokerage accounts following the 1-for-35 consolidation.
- Review the adjusted exercise prices and share quantities for any outstanding stock options or warrants.
- Check the Company's subsequent filings for any updates on Nasdaq compliance status post-split.